The Life History of 21 Breast Cancers

Cited by (1,000)

Items 701–800 of 1,000

1. Quantifying the influence of mutation detection on tumour subclonal reconstruction
   Lydia Liu, Vinayak Bhandari, Adriana Salcedo, Shadrielle M. G. Espiritu, Quaid Morris, Thomas Kislinger, Paul Christopher Boutros · 2020 · Nature Communications
2. Find the path of least resistance: Adaptive therapy to delay treatment failure and improve outcomes
   Craig A. Gedye, Vishal Navani · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
3. A pan-tissue survey of mosaic chromosomal alterations in 948 individuals
   Teng Gao, Maria Eleni Kastriti, Viktor Ljungström, Andreas Heinzel, Arthur S. Tischler, Rainer W. Oberbauer, Po‐Ru Loh, Igor I. Adameyko, Peter J. Park, Peter V. Kharchenko · 2023 · Nature Genetics
4. Pre‐tumour clones, periodic selection and clonal interference in the origin and progression of gastrointestinal cancer: potential for biomarker development
   Ann‐Marie Baker, Trevor A. Graham, Nicholas A Wright · 2013 · The Journal of Pathology
5. Cancer networks and beyond: Interpreting mutations using the human interactome and protein structure
   Sakshi Gulati, Tammy M. K. Cheng, Paul A. Bates · 2013 · Seminars in Cancer Biology
6. Developmental Insights into Breast Cancer Intratumoral Heterogeneity
   Mei Zhang, Jeffrey M. Rosen · 2015 · Trends in cancer
7. A headlight on liquid biopsies: a challenging tool for breast cancer management
   Daniela Massihnia, Alessandro Perez, Viviana Bazan, Giuseppe Bronte, Marta Castiglia, Daniele Fanale, Nadia Barraco, Antonina Graziella Cangemi, F. Di Piazza, Valentina Calò et al. · 2016 · Tumor Biology
8. A core program of gene expression characterizes cancer metastases
   Franz Hartung, Yunguan Wang, Bruce J. Aronow, Georg F. Weber · 2017 · Oncotarget
9. Delineation of human prostate cancer evolution identifies chromothripsis as a polyclonal event and FKBP4 as a potential driver of castration resistance
   Joël R. Federer‐Gsponer, Cristina Quintavalle, David Christian Müller, Tanja Dietsche, Valeria Perrina, Thomas Lorber, Darius Juškevičius, Elizabeth Lenkiewicz, Tobias Zellweger, Thomas Gasser et al. · 2018 · The Journal of Pathology
10. Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
    Elen Höglander, Silje Nord, David C. Wedge, Ole Christian Lingjærde, Laxmi Silwal‐Pandit, Hedda von der Lippe Gythfeldt, Hans Kristian Moen Vollan, Thomas Fleischer, Marit Krohn, Ellen Schlitchting et al. · 2018 · Genome Medicine
11. Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer
    Jamie R. Kutasovic, Amy E. McCart Reed, Anna Sokolova, Sunil R. Lakhani, Peter T. Simpson · 2020 · Cancers
12. Reconstruction of clone- and haplotype-specific cancer genome karyotypes from bulk tumor samples
    Sergey S. Aganezov, Benjamin J. Raphael · 2020 · Genome Research
13. Tumor Heterogeneity: Focus on the Leaves, the Trees, or the Forest?
    Joel S. Parker, Charles M. Perou · 2015 · Cancer Cell
14. Pathogenesis and Molecular Biology of a Transmissible Tumor in the Tasmanian Devil
    Hannah S. Bender, Jennifer A. Marshall Graves, Janine E. Deakin · 2013 · Annual Review of Animal Biosciences
15. Identification of High-Impact cis-Regulatory Mutations Using Transcription Factor Specific Random Forest Models
    Dmitry Svetlichnyy, Hana Imrichová, Mark W. E. J. Fiers, Zeynep Kalender Atak, Stein Aerts · 2015 · PLoS Computational Biology
16. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers
    Omer M. Toor, Zaheer Ahmed, Waled Bahaj, Urooge Boda, Lee S. Cummings, Megan E. McNally, Kevin F. Kennedy, Timothy Pluard, Arif Hussain, Janakiraman Subramanian et al. · 2018 · Molecular Cancer Therapeutics
17. Engineering Multidimensional Evolutionary Forces to Combat Cancer
    Caroline Elizabeth McCoach, Trever Grant Bivona · 2019 · Cancer Discovery
18. The Genomic Processes of Biological Invasions: From Invasive Species to Cancer Metastases and Back Again
    Fargam Neinavaie, Arig Ibrahim‐Hashim, Andrew M. Kramer, Joel S. Brown, Christina L. Richards · 2021 · Frontiers in Ecology and Evolution
19. Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies
    Uri Galili · 2021 · Frontiers in Molecular Biosciences
20. Reconstructing clonal tree for phylo-phenotypic characterization of cancer using single-cell transcriptomics
    Seong-Hwan Jun, Hosein Toosi, Jeff Eron Mold, Camilla Engblom, Xinsong Chen, Ciara H. O’Flanagan, Michael Hagemann-Jensen, Rickard Sandberg, Samuel A. J. R. Aparicio, Johan Hartman et al. · 2023 · Nature Communications
21. The intra-tumor heterogeneity of cell signaling factors in breast cancer: p4E-BP1 and peIF4E are diffusely expressed and are real potential targets
    Santiago Ramón y Cajal, Leticia De Mattos‐Arruda, Nahum Sonenberg, Javier Cortés, Vicente Peg · 2014 · Clinical & Translational Oncology
22. Novel mutational landscapes and expression signatures of lung squamous cell carcinoma
    Donghai Xiong, Jing Pan, Yuxin Yin, Hui Jiang, Eva M. Szabo, Ronald A. Lubet, Yian Wang, Ming You · 2017 · Oncotarget
23. Applications of Single-Cell Sequencing for Multiomics
    Yungang Xu, Xiaobo Zhou · 2018 · Methods in molecular biology
24. Update on Sporadic Colorectal Cancer Genetics
    Karin M. Hardiman · 2018 · Clinics in Colon and Rectal Surgery
25. Organoids reveal cancer dynamics
    Calvin Jay Kuo, Christina N. Curtis · 2018 · Nature
26. Germline and somatic variations influence the somatic mutational signatures of esophageal squamous cell carcinomas in a Chinese population
    Jintao Guo, Jiankun Huang, Ying Zhou, Yulin Zhou, Liying Yu, Huili Li, Lingyun Hou, Liuwei Zhu, Dandan Ge, Yuanyuan Zeng et al. · 2018 · BMC Genomics
27. Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data
    J. Abécassis, Anne‐Sophie Hamy, Cécile Laurent, Benjamin Sadacca, Hélène Bonsang‐Kitzis, Fabien Reyal, Jean‐Philippe Vert · 2019 · PLoS ONE
28. Multi-color clonal tracking reveals intra-stage proliferative heterogeneity during mammary tumor progression
    Stefanie Tiede, Ravi Kiran Reddy Kalathur, Fabiana Lüönd, Luca von Allmen, Barbara Maria Szczerba, Mathias Hess, Tatjana Vlajnic, Benjamin Müller, James Canales Murillo, Nicola Aceto et al. · 2020 · Oncogene
29. The History of Chromosomal Instability in Genome-Doubled Tumors
    Toby M. Baker, Siqi Lai, Andrew R. Lynch, Tom Lesluyes, Haixi Yan, Huw A. Ogilvie, Annelien Verfaillie, Stefan C. Dentro, Amy L. Bowes, Nischalan Pillay et al. · 2024 · Cancer Discovery
30. Catalog of genetic progression of human cancers: breast cancer
    Christine Desmedt, Lucy R. Yates, Janina Kulka · 2016 · Cancer and Metastasis Reviews
31. Bulk Genotyping of Biopsies Can Create Spurious Evidence for Hetereogeneity in Mutation Content
    Rumen L. Kostadinov, Carlo C. Maley, Mary K. Kuhner · 2016 · PLoS Computational Biology
32. eTumorType, An Algorithm of Discriminating Cancer Types for Circulating Tumor Cells or Cell-Free DNAs in Blood
    Jinfeng Zou, Edwin Wang · 2017 · Genomics Proteomics & Bioinformatics
33. Targeted sequencing reveals the somatic mutation landscape in a Swedish breast cancer cohort
    Argyri Mathioudaki, Viktor Ljungström, Malin Melin, Maja L. Arendt, Jessika Nordin, Åsa Karlsson, Eva Murén, Pushpa Saksena, Jennifer R. S. Meadows, Voichita Dana Marinescu et al. · 2020 · Scientific Reports
34. Somatic variants in epilepsy – advancing gene discovery and disease mechanisms
    Erin L. Heinzen · 2020 · Current Opinion in Genetics & Development
35. Detection of Oncogenic and Clinically Actionable Mutations in Cancer Genomes Critically Depends on Variant Calling Tools
    Carlos Antonio García-Prieto, Francisco Martínez-Jiménez, Alfonso Valencia, Eduard Porta‐Pardo · 2020 · Bioinformatics
36. WITHDRAWN: Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas
    Xiaofan Ding, Mian He, Anthony W.H. Chan, Qi Xiu Song, Siu Ching Sze, Hui Chen, K Man, Kwan Man, Stephen Lam Chan, Paul B.S. Lai et al. · 2020 · Gastroenterology · Retracted
37. RB1 loss triggers dependence on ESRRG in retinoblastoma
    Matthew G. Field, Jeffim N. Kuznetsoff, Michelle G. Zhang, James Jarad Dollar, Michael A. Durante, Yoseph Sayegh, Christina L. Decatur, Stefan Kurtenbach, Daniel Pelaez, J. William Harbour · 2022 · Science Advances
38. Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
    Matthew E. Stokes, Kerstin Wenzl, C. Chris Huang, María Ortiz, Chih-Chao Hsu, Matthew John Maurer, Nicholas Stong, Yumi Nakayama, Lei Wu, Hsiling Chiu et al. · 2024 · Nature Communications
39. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment
    Anthony J. Apostoli, Laurie Ailles · 2015 · Critical Reviews in Clinical Laboratory Sciences
40. Genetic alterations of triple negative breast cancer (TNBC) in women from Northeastern Mexico
    Grecia Uscanga‐Perales, Sandra Karina Santuario-Facio, Celia Nohemi Sanchez-Dominguez, Servando Cardona‐Huerta, Gerardo Enrique Muñoz-Maldonado, Pablo Ruíz-Flores, Jose Ramon Barcenas-Walls, Luis Ernesto Osuna-Rosales, Augusto Rojas‐Martínez, Juan Francisco González-Guerrero et al. · 2019 · Oncology Letters
41. Combined landscape of single-nucleotide variants and copy-number alterations in clonal hematopoiesis
    Ryunosuke Saiki, Yukihide Momozawa, Yasuhito Nannya, Masahiro Marshall Nakagawa, Yotaro Ochi, Tetsuichi Yoshizato, Chikashi Terao, Yutaka Kuroda, Yuichi Shiraishi, Kenichi Chiba et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
42. Preprocancer
    Douglas E. Brash · 2015 · Science
43. Computational validation of clonal and subclonal copy number alterations from bulk tumor sequencing using CNAqc
    Alice Antonello, Riccardo Bergamin, Nicola Calonaci, Jacob Househam, Salvatore Milite, Marc J. Williams, Fabio Anselmi, Alberto d’Onofrio, Vasavi Sundaram, Alona Sosinsky et al. · 2024 · Genome biology
44. Genomic landscape of adult testicular germ cell tumours in the 100,000 Genomes Project
    Máire Ní Leathlobhair, Anna Frangou, Ben Kinnersley, Alex J. Cornish, Daniel Chubb, Eszter Lakatos, Prabhu Arumugam, Andreas J Gruber, Philip Law, Avraam Tapinos et al. · 2024 · Nature Communications
45. Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia
    Aleksandra E Kamizela, Daniel A. Leongamornlert, Nicholas Williams, Xin Wang, Kudzai Nyamondo, Kevin J. Dawson, Michael Spencer Chapman, Jing Guo, Joe Lee, Karim Mané et al. · 2025 · Nature
46. Next generation analysis of breast cancer genomes for precision medicine
    Maurizio Previati, Marco Manfrini, Marco Galasso, Carlotta Zerbinati, Jeff Palatini, Pierluigi Gasparini, Stefano Volinia · 2013 · Cancer Letters
47. Artificial Intelligence in Oncology Drug Discovery and Development
    John W. Cassidy, Belle Taylor · 2020 · IntechOpen eBooks
48. Re-evaluating experimental validation in the Big Data Era: a conceptual argument
    Mohieddin Jafari, Yuanfang Guan, David C. Wedge, Naser Ansari‐Pour · 2021 · Genome biology
49. Cancer drivers and clonal dynamics in acute lymphoblastic leukaemia subtypes
    James B. Studd, Alex J. Cornish, Phuc H. Hoang, Philip Law, Ben Kinnersley, Richard S. Houlston · 2021 · Blood Cancer Journal
50. Natural Barcodes for Longitudinal Single Cell Tracking of Leukemic and Immune Cell Dynamics
    Livius Penter, Satyen Harish Gohil, Catherine J. Wu · 2022 · Frontiers in Immunology
51. Clonal diversification and histogenesis of malignant germ cell tumours
    Thomas R. W. Oliver, Lia Chappell, Rashesh Sanghvi, Lauren Deighton, Naser Ansari‐Pour, Stefan C. Dentro, Matthew D. Young, Tim H. H. Coorens, Hyunchul Jung, Timothy M. Butler et al. · 2022 · Nature Communications
52. Reconstructing phylogenetic trees from genome-wide somatic mutations in clonal samples
    Tim H. H. Coorens, Michael Spencer Chapman, Nicholas Williams, Iñigo Martincorena, Michael R. Stratton, Jyoti Nangalia, Peter J. Campbell · 2024 · Nature Protocols
53. Evolution of chromosome-arm aberrations in breast cancer through genetic network rewiring
    Kuzmin, Elena, Baker, Toby M., Lesluyes, Tom, Monlong, Jean, Abe, Kento T., Coelho, Paula P., Schwartz, Michael, Del Corpo, Joseph, Zou, Dongmei, Morin, Genevieve et al. · 2024 · Cell Reports
54. The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high‐grade transformation
    Samuel Backman, Johan Botling, Helena Nord, Suman Ghosal, Peter L. H. Stalberg, C. Christofer Juhlin, Jonas Carlsson Almlöf, Anders Sundin, Liang Zhang, Lotte Moens et al. · 2024 · The Journal of Pathology
55. PeSV-Fisher: Identification of Somatic and Non-Somatic Structural Variants Using Next Generation Sequencing Data
    Geòrgia Escaramís, Cristian Tornador, Laia Bassaganyas, Raquel Rabionet, José M. C. Tubío, Alexander Martinez‐Fundichely, Mario Cáceres, Marta Gut, Stephan Ossowski, Xavier Estivill · 2013 · PLoS ONE
56. Genomic profiling of breast cancers
    Christina N. Curtis · 2014 · Current Opinion in Obstetrics & Gynecology
57. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells
    Xiuwen Guan, Fei Ma, Suyan Liu, Shiyang Wu, Rong Xiao, Lifang Yuan, Xiaoying Sun, Zongbi Yi, Huiyi Yang, Binghe Xu · 2016 · Oncotarget
58. Visualization of tumor heterogeneity by in situ padlock probe technology in colorectal cancer
    Amin El Heliebi, Karl Kashofer, Julia Fuchs, Stephan Wenzel Jahn, Christian Viertler, Andrija Matak, Peter Sedlmayr, Gerald Höefler · 2017 · Histochemistry and Cell Biology
59. Immuno-oncology from the perspective of somatic evolution
    Santiago González, Nadezda V. Volkova, Philip A. Beer, Moritz Gerstung · 2017 · Seminars in Cancer Biology
60. Systemic Metabolism, Its Regulators, and Cancer: Past Mistakes and Future Potential
    Jeff M.P. Holly, Kalina M. Biernacka, Claire M. Perks · 2019 · Frontiers in Endocrinology
61. Intratumoral heterogeneity and subclonal diversification of early breast cancer
    Lucy R. Yates · 2017 · The Breast
62. The niche under siege: novel targets for metastasis therapy
    Albert Santamaria‐Martínez, Joerg Huelsken · 2013 · Journal of Internal Medicine
63. Mutation signatures reveal biological processes in human cancer
    Kyle R. Covington, Eve Shinbrot, David A. Wheeler · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
64. Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer
    Kara N. Maxwell, Danielle Soucier-Ernst, Emin Tahirović, Andrea B. Troxel, Candace Clark, Michael D. Feldman, Christopher Colameco, Bijal Kakrecha, Melissa Langer, David B. Lieberman et al. · 2017 · Breast Cancer Research and Treatment
65. Genomic evolution of uveal melanoma arising in ocular melanocytosis
    Michael A. Durante, Matthew G. Field, Margaret I. Sanchez, Kyle R. Covington, Christina L. Decatur, Sander R. Dubovy, J. William Harbour · 2019 · Molecular Case Studies
66. Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Kelly L. Bolton, Ryan N. Ptashkin, Teng Gao, Lior Zvi Braunstein, Sean M. Devlin, Daniel John Kelly, Minal A. Patel, Antonin Berthon, Aijazuddin Syed, Mariko Yabe et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
67. Intratumoral heterogeneity and consequences for targeted therapies
    Andrei Turtoï, Arnaud Blomme, Vincent Castronovo · 2015 · Bulletin du Cancer
68. Serum microRNA as Potential Biomarker to Detect Breast Atypical Hyperplasia and Early-Stage Breast Cancer
    Xuefeng An, Hong Quan, Jinhui Lv, Lingyu Meng, Cheng Wang, Zuoren Yu, Jing Han · 2018 · Future Oncology
69. The Impact of Next Generation Sequencing in Cancer Research
    Kátia Nones, Ann‐Marie Patch · 2020 · Cancers
70. CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data
    J. Abécassis, Fabien Reyal, Jean‐Philippe Vert · 2021 · Nature Communications
71. Multi-scale characterisation of homologous recombination deficiency in breast cancer
    Daniel H. Jacobson, Pan Shi, Jasmin Fisher, Maria Secrier · 2023 · Genome Medicine
72. Humanization of the mouse mammary gland by replacement of the luminal layer with genetically-engineered preneoplastic human cells
    Stéphanie Verbeke, Élodie Richard, Elodie Monceau, Xenia Schmidt, Benoı̂t Rousseau, Valérie Velasco, David Bernard, Herve R. Bonnefoi, Gaëtan Marie MacGrogan, Richard D Iggo · 2014 · Breast Cancer Research
73. Reconstructing Mutational History in Multiply Sampled Tumors Using Perfect Phylogeny Mixtures
    Iman Hajirasouliha, Benjamin J. Raphael · 2014 · Lecture notes in computer science
74. The Copy-Number Tree Mixture Deconvolution Problem and Applications to Multi-sample Bulk Sequencing Tumor Data
    Simone Zaccaria, Mohammed El-Kebir, Gunnar W. Klau, Benjamin J. Raphael · 2017 · Lecture notes in computer science
75. Identification of copy number alterations in colon cancer from analysis of amplicon-based next generation sequencing data
    Duarte Mendes Oliveira, Gianluca Santamaria, Carmelo Laudanna, Simona Migliozzi, Pietro Zoppoli, Michael J. Quist, Catie Grasso, Chiara Mignogna, Laura Elia, Maria Concetta Faniello et al. · 2018 · Oncotarget
76. Evolutionary dynamics in Barrett oesophagus: implications for surveillance, risk stratification and therapy
    Melissa Schmidt, RICHARD J. HACKETT, Ann‐Marie Baker, Stuart A.C. McDonald, Michael Quante, Trevor A. Graham · 2021 · Nature Reviews Gastroenterology & Hepatology
77. Breast Cancer Intra-Tumor Heterogeneity: One Tumor, Different Entities
    José Esparza‐López, Elizabeth Escobar-Arriaga, Santos Soto-Germes, Marı́a de Jesús Ibarra-Sánchez · 2017 · Revista de investigaci�n Cl�nica
78. Precise identification of cancer cells from allelic imbalances in single cell transcriptomes
    Mi K. Trinh, Clarissa N. Pacyna, Gerda Kildisiute, Christine Thevanesan, Alice Piapi, Kirsty Ambridge, Nathaniel D. Anderson, Eleonora Khabirova, Elena Prigmore, Karin C. M. Straathof et al. · 2022 · Communications Biology
79. The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
    Claudia Buhigas, Anne Yvonne Warren, Wing‐Kit Leung, Hayley C. Whitaker, Hayley J. Luxton, Steve F. C. Hawkins, Jonathan D. Kay, Adam P. Butler, Yaobo Xu, Dan J. Woodcock et al. · 2022 · Molecular Cancer
80. Genomic evolution shapes prostate cancer disease type
    Dan J. Woodcock, Atef Sahli, Ruxandra Teslo, Vinayak Bhandari, Andreas J Gruber, Aleksandra Ziubroniewicz, Gunes Gundem, Yaobo Xu, Adam P. Butler, Ezequiel Anokian et al. · 2024 · Cell Genomics
81. The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations
    Margherita Bodini, Chiara Ronchini, Luciano Giacò, Anna Russo, Giorgio E. M. Melloni, Lucilla Luzi, Domenico Sardella, Sara Volorio, Syed K. Hasan, Tiziana Ottone et al. · 2014 · Blood
82. MicroRNA-203 represses selection and expansion of oncogenic Hras transformed tumor initiating cells
    Kent A. Riemondy, Xiao‐Jing Wang, Enrique C. Torchia, Dennis R. Roop, Rui Yi · 2015 · eLife
83. An evolutionary perspective on anti-tumor immunity
    David J. Klinke · 2013 · Frontiers in Oncology
84. ‘Omics Approaches in Breast Cancer Research and Clinical Practice
    Priyakshi Kalita‐de Croft, Fares Al‐Ejeh, Amy E. McCart Reed, Jodi M. Saunus, Sunil R. Lakhani · 2016 · Advances in Anatomic Pathology
85. Targeted Gene Sequencing of Gallbladder Carcinoma Identifies High-impact Somatic and Rare Germline Mutations
    Saurabh Yadav, Navonil De Sarkar, Niraj Kumari, Narendra Krishnani, Ashok Kumar, Balraj Mittal · 2017 · Cancer Genomics & Proteomics
86. An enhanced genetic model of relapsed IGH-translocated multiple myeloma evolutionary dynamics
    Phuc H. Hoang, Alex J. Cornish, Amy L. Sherborne, Daniel Chubb, Scott T. Kimber, Graham Hunter Jackson, Gareth John Morgan, Gordon Cook, Ben Kinnersley, Martin Kaiser et al. · 2020 · Blood Cancer Journal
87. Intratumoral functional heterogeneity and chemotherapy
    Ferenc Sípos · 2014 · World Journal of Gastroenterology
88. Lobular Breast Cancer: Pathology, Biology, and Options for Clinical Intervention
    Eva J. Vlug, Cigdem Ercan, Elsken van der Wall, P. J. van Diest, Patrick W.B. Derksen · 2013 · Archivum Immunologiae et Therapiae Experimentalis
89. Determining causal miRNAs and their signaling cascade in diseases using an influence diffusion model
    Joseph J. Nalluri, Pratip Rana, Debmalya Barh, Vasco Azevedo, Thang N. Dinh, Vladimir I. Vladimirov, Preetam Ghosh · 2017 · Scientific Reports
90. Ferroptosis and cancer: when iron turns against tumors
    Shinya Toyokuni, Yingyi Kong, Yuki K. Maeda, Qinying Lyu, Yuuki Ohara, Kotaro Sato, Yashiro Motooka, Kae Nakamura, Hiromasa Tanaka · 2025 · Cellular and Molecular Life Sciences
91. Aptamer: A theranostic approach towards breast cancer
    Shubhi Rana, Deepti Kaushik, Aprajita Singh, Deeksha Gautam, Janhavi Rai, Jitendra Singh Rathore · 2023 · Clinical Immunology Communications
92. Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis
    Omar Najim, Konstantinos Papadimitriou, Glenn Broeckx, Manon Thirza Huizing, Wiebren A.A. Tjalma · 2023 · Frontiers in Oncology
93. Evolving copy number gains promote tumor expansion and bolster mutational diversification
    Zicheng Wang, Yunong Xia, Lauren Mills, Αθανάσιος Ν. Νικολακόπουλος, Nicole Maeser, Scott M. Dehm, Jason M. Sheltzer, Ruping Sun · 2024 · Nature Communications
94. Navigating Breast Cancer Oligometastasis and Oligoprogression: Current Landscape and Future Directions
    Stephanie M Yoon, Jose G. Bazan · 2024 · Current Oncology Reports
95. HATCHet2: clone- and haplotype-specific copy number inference from bulk tumor sequencing data
    Matthew A. Myers, Brian J. Arnold, Vineet Bansal, Metin Balaban, Katelyn M. Mullen, Simone Zaccaria, Benjamin J. Raphael · 2024 · Genome biology
96. Single-cell copy number calling and event history reconstruction
    Jack Kuipers, Anıl Tuncel, Pedro Ferreira, Katharina Jahn, Niko Beerenwinkel · 2025 · Bioinformatics
97. ABSOLUTE cancer genomics
    Peter Van Loo, Peter J. Campbell · 2012 · Nature Biotechnology
98. The translation of cancer genomics: time for a revolution in clinical cancer care
    Elaine R. Mardis · 2014 · Genome Medicine
99. Sequencing the AML Genome, Transcriptome, and Epigenome
    Elaine R. Mardis · 2014 · Seminars in Hematology
100. From genome integrity to cancer
     Serena Nik‐Zainal · 2019 · Genome Medicine